The law has to catch up on orphan-designated drugs with multiple uses

A 340B rebate pilot collides with an ongoing problem for small pharmacies: when orphan-designated drugs have multiple uses.

340B药品折扣项目的孤儿药排除条款按药品认定而非实际适应症执行，使药房配发用于常见病的孤儿药时反而亏损。作者主张HRSA在回扣试点的申报数据中加入诊断信息，并由国会修法把排除条件改为按实际用途判断。